Innophos to Launch New Co-Processed, Multifunctional Excipient A-Tab® MD at CPhI Worldwide 2019
November 04 2019 - 9:00AM
Business Wire
A-Tab® MD Improves Manufacturing
Efficiencies for Pharmaceutical and Nutraceutical Tablet and
Capsule Formulations While Addressing Consumer Preference for
Smaller, More Convenient Tablet Sizes
Innophos Holdings, Inc. (NASDAQ:IPHS), a leading international
producer of essential ingredients, today announced that it is
expanding its portfolio of co-processed, multifunctional excipients
with the launch of A-Tab® MD at the CPhI 2019 tradeshow and expo
taking place November 5-7 at the Messe Frankfurt GmbH in Frankfurt,
Germany.
A-Tab® MD is a label-friendly, multifunctional excipient
demonstrated to significantly enhance compressibility and simplify
formulations of pharmaceutical and nutraceutical tablets and
capsules. As a result, with A-Tab® MD, formulators can improve
manufacturing efficiency, increase performance and deliver smaller
tablet sizes to meet consumer preferences. With the launch of
A-Tab® MD, Innophos further expands its growing portfolio of
co-processed, multifunctional excipients that include Nutra-Tab®
and Tri-Tab® PVP.
“A-Tab® MD delivers important value to manufacturers and
consumers alike. Formulators are continually seeking solutions to
help improve powder flow, tablet robustness, and processing
efficiency while consumers prefer smaller and more convenient
tablet sizes to support their health and wellness routines. A-Tab®
MD helps address both these needs while also providing superior
functionality,” said Sherry D. Duff, SVP, Chief Marketing and
Technology Officer. She continues, “We are proud of the
advancements we have made with our co-processed, multifunctional
excipients and look forward to sharing our market-leading solutions
at CPhI Worldwide.”
Innophos will be showcasing its portfolio of co-processed,
multifunctional excipients, including A-Tab® MD, in booth #102D92
at CPhI Worldwide. Bringing together over 45,000 visitors and 2,500
exhibitors from more than 165 countries under one roof, CPhI
Worldwide is one of the largest and most important global
pharmaceutical trade fairs.
About the Company
Innophos is a leading international producer of essential
ingredients. We partner with world-leading health & nutrition,
food & beverage and industrial brands to create science-based
solutions that improve quality of life. Our knowledgeable teams
apply science to unlock the potential that lies within the blends
and formulations that we deliver. Forward thinking and people
centric at heart, we execute with purpose and efficiency to create
value in everything we do. Headquartered in Cranbury, New Jersey,
Innophos has manufacturing operations across the United States, in
Canada, Mexico and China. For more information, please visit
www.innophos.com 'IPHS-G'
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191104005502/en/
Investor Contact Mark Feuerbach Innophos 609-366-1204
investor.relations@innophos.com Media Contact Ryan Flaim
Sharon Merrill Associates 617-542-5300
iphs@investorrelations.com
Innophos (NASDAQ:IPHS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Innophos (NASDAQ:IPHS)
Historical Stock Chart
From Oct 2023 to Oct 2024